Oncosec Medical Inc
ONCSDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444307
Oncosec Medical Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Feb 9, 2023; 23 institutions reported holding it in 13F filings for Q3 2022, worth $2.51M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Oncosec Medical Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ONCS is no longer listed, so this page shows Q3 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 23
- −3 vs. Q2 2022
- Shares held
- 5.15M
- −53.0K (−1.0%) vs. Q2 2022
- Total value
- $2.51M
- −$1.35M (−34.9%) vs. Q2 2022
- New holders
- 1
- 5 more added
- Sold out
- 4
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 23 | $2.51M |
| Q2 2022 | 26 | $3.86M |
| Q1 2022 | 31 | $6.09M |
| Q4 2021 | 35 | $5.31M |
| Q3 2021 | 33 | $13.8M |
| Q2 2021 | 36 | $19.2M |
| Q1 2021 | 35 | $36.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Oncosec Medical Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avidity Partners Management LP | 2,945,000 | $1.44M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 717,486 | $350.0K | 0.00% | −14,030−1.9% | Reduced |
| Bank of New York Mellon Corp | 383,491 | $187.0K | 0.00% | 00.0% | Unchanged |
| Salzhauer Michael | 296,282 | $145.0K | 0.09% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 274,196 | $133.0K | 0.00% | +1,944+0.7% | Added |
| Tocqueville Asset Management L.P. | 75,500 | $37.0K | 0.00% | +1,000+1.3% | Added |
| Long Focus Capital Management, LLC | 69,226 | $34.0K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 67,398 | $33.0K | 0.00% | −5,500−7.5% | Reduced |
| Susquehanna International Group, LLP | 62,229 | $30.0K | 0.00% | +13,759+28.4% | Added |
| State Street Corp | 43,729 | $21.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 39,996 | $20.0K | 0.00% | 00.0% | Unchanged |
| Regentatlantic Capital LLC | 34,387 | $17.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 30,980 | $16.0K | 0.00% | −14,280−31.6% | Reduced |
| Sandbox Financial Partners, LLC | 25,000 | $12.0K | 0.01% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 22,900 | $11.0K | 0.00% | +100+0.4% | Added |
| Citadel Advisors LLC | 15,640 | $8.00K | 0.00% | −37,094−70.3% | Reduced |
| Moloney Securities Asset Management, LLC | 11,850 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 12,954 | $6.00K | 0.00% | +7,478+136.6% | Added |
| Virtu Financial LLC | 11,935 | $6.00K | 0.00% | +11,935 | New |
| Group One Trading, L.P. | 6,529 | $3.00K | 0.00% | −629−8.8% | Reduced |
| Bank of America Corp | 2,000 | $1.00K | 0.00% | −160−7.4% | Reduced |
| Morgan Stanley | 1,567 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 125 | $0 | 0.00% | −1−0.8% | Reduced |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −65−100.0% | Sold out |